Form 4 for BHVN Biohaven Ltd.
Accepted 2023-12-29 00:00:00 ET · period of report 2023-12-29 · accession 0001562180-23-008590 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-29 | 2023-12-29 | BHVN | Antonijevic Irina | Dir | M - OptEx | $0.00 | +11.0K | 13.5K | +434% | $0 |
| D | 2023-12-29 | 2023-12-29 | BHVN | Antonijevic Irina | Dir | S - Sale+OE | $41.79 | -11.0K | 2,535 | -81% | -$459.7K |
| D | 2023-12-29 | 2023-12-29 | BHVN | Antonijevic Irina | Dir | M - OptEx | $0.00 | -11.0K | 114.0K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-12-29 | M | A | 11,000 | $0.00 | 13,535 | D | — | — | |
| 2 | Common | Common Shares | 2023-12-29 | S | D | 11,000 | $41.79 | 2,535 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.74 - $41.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 3 | Derivative | Stock Options (Right to Buy) | 2023-12-29 | M | D | 11,000 | $0.00 | 114,000 | D | $7.00 · — to 2032-10-03 | 11,000 Common Shares | (F2) The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date. |